Q&A With Kate Dawson From Biogen: Tecfidera Continues To Show Positive Results For Multiple Sclerosis Patients

Video

Tecfidera has been on the market for a few years to help treat relapsing remitting multiple sclerosis and through extended studies and watching the market positive results have been seen by patients using the oral treatment.

Tecfidera has been on the market for a few years to help treat relapsing remitting multiple sclerosis and through extended studies and watching the market positive results have been seen by patients using the oral treatment.

Kate Dawson, MD, the Vice President of the US Medical Group for Biogen discussed continued reearch on the treatment during the annual ECTRIMS conference in Barcelona.

Related Videos
Vlado Perkovic, MBBS, PhD | Credit: George Institute of Global Health
Elizabeth Aby, MD | Credit: Minnesota Health Fairview
Prashant Singh, MD | Credit: University of Michigan
Noa Krugliak Cleveland, MD | Credit: University of Chicago
Caroline Sisson, MMS, PA-C: Updates in Pulmonary Function Testing
Ali Rezaie, MD | Credit: X
Should We Reclassify Diabetes Subtypes?
Remo Panaccione, MD | Credit: University of Calgary
Francisca Joly, MD, PhD | Credit: The Transplantation Society
Primary Care Roles in Alzheimer Diagnosis, with Theresa Sivers-Teixeira, MSPA, PA-C
© 2024 MJH Life Sciences

All rights reserved.